Scrip Regulatory Affairs
Australia's TGA updates risk management strategy with biologicals regulatory framework
02 September 2011
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Australia's TGA publishes consolidated guide for biologicals framework
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- New biologicals framework effective in Australia; TGA calls for applications for ARTG listing
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
